SCHEMBL6299443

SCHEMBL6299443

Cc1ccc(S)c(CCCl)c1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.39
ALDH1A1 P00352 5/20 0.37
MAPT P10636 4/20 0.37
POLB P06746 2/20 0.37
THRB P10828 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 1/20 0.36
GPR55 Q9Y2T6 2/20 0.35
KMT2A Q03164 1/20 0.33
AMY1A P0DUB6 1/20 0.33
CYP2A6 P11509 3/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP1A2 P05177 2/20 0.32
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11862519 0.80 TAAR1 (0.43) TAAR1ALDH1A1MAPTPOLBTHRB
SCHEMBL3125997 0.78 TAAR1 (0.63) TAAR1ALDH1A1MAPTPOLBTHRB
SCHEMBL8416454 0.78 TYR (0.40) TAAR1ALDH1A1MAPTPOLBTHRB
SCHEMBL6299246 0.77 IDO1 (0.39) ALDH1A1MAPTKMT2ACYP2A6TDP1
SCHEMBL18231539 0.76 MAPT (0.39) TAAR1ALDH1A1MAPTPOLBTHRB
SCHEMBL6537098 0.76 IDO1 (0.42) TAAR1ALDH1A1THRBAMY1ACYP2A6
SCHEMBL16974976 0.75 TAAR1 (0.39) TAAR1ALDH1A1MAPTPOLBTHRB
SCHEMBL11272694 0.75 TYR (0.43) TAAR1ALDH1A1MAPTTHRBNPSR1
SCHEMBL11853446 0.74 TAAR1 (0.42) TAAR1ALDH1A1MAPTPOLBNPSR1
SCHEMBL27628977 0.74 AMY1A (0.39) TAAR1ALDH1A1KMT2AAMY1ACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6942966-B1 libraries formed by permutations; combinatorial chemistry; drug screening ISIS PHARMACEUTICALS, INC. (US) 2005-09-13 US disclosed
US-6559303-B1 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical ISIS PHARMACEUTICALS, INC. 2003-05-06 US disclosed
US-6329523-B1 FOR ANTIBACTERIAL PHARMACEUTICAL USE, USEFUL FOR IDENTIFYING METAL CHELATING SPECIES FOR ?HEAVY METAL? THERAPY; IMAGING AGENTS ISIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
US-6207826-B1 Macrocyclic compounds having nitrogen-containing linkages ISIS PHARMACEUTICALS, INC. 2001-03-27 US disclosed
US-6197965-B1 POLYARYLALKYLAMINO-SUBSTITUED PYRIDINE DERIVATIVES; DRUGS, MEDICINE, DIAGNOSTICS ISIS PHARMACEUTICALS, INC. 2001-03-06 US disclosed
EP-0817787-A4 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2000-09-13 EP disclosed
WO-1998010286-A1 METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS ISIS PHARMACEUTICALS, INC. (US) 1998-03-12 WO disclosed
EP-0817787-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1998-01-14 EP disclosed
WO-1996030377-A1 NITROGENOUS MACROCYCLIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 1996-10-03 WO disclosed